BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36708576)

  • 1. Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study.
    Edirisinghe ST; Weerasekera M; De Silva DK; Devmini MT; Pathmaperuma S; Wijesinghe GK; Nisansala T; Maddumage A; Huzaini H; Rich AM; De Silva H; Trudy M; Goonasinghe R; De Silva K; Yasawardena S
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):267-274. PubMed ID: 36708576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of angiopoietin-2 and vascular endothelial growth factor receptor-3 correlates with lymphangiogenesis and angiogenesis and affects survival of oral squamous cell carcinoma.
    Li C; Fan J; Song X; Zhang B; Chen Y; Li C; Mi K; Ma H; Song Y; Tao X; Li G
    PLoS One; 2013; 8(9):e75388. PubMed ID: 24040410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
    Lalla RV; Boisoneau DS; Spiro JD; Kreutzer DL
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):882-8. PubMed ID: 12925349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
    Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA
    J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunohistochemical expression of vascular endothelial growth factor and CD105 in oral squamous cell carcinoma: Its correlation with prognosis.
    Patil BR; Bhat K; Somannavar P; Hosmani J; Kotrashetti V; Nayak R
    J Cancer Res Ther; 2018; 14(2):421-427. PubMed ID: 29516931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.
    Sun Q; Zhang T; Xiao Q; Mei B; Zhang X
    Bioengineered; 2022 Mar; 13(3):6500-6508. PubMed ID: 35220896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
    Agnihotri NS; Astekar M
    J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse correlation of CD3 & vascular endothelial growth factor in incisional oral squamous cell carcinoma biopsies predicts nodal metastasis & poor survival of patients.
    Khan W; Augustine D; Rao RS
    Indian J Med Res; 2023 May; 157(5):438-446. PubMed ID: 37322630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and nm23-H1 in oral squamous cell carcinoma].
    Xu JC; Feng ZZ; Zhao SF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Nov; 42(11):681-3. PubMed ID: 18307927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
    Al-Dissi AN; Haines DM; Singh B; Kidney BA
    Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma.
    Li C; Sun CJ; Fan JC; Geng N; Li CH; Liao J; Mi K; Zhu GQ; Ma H; Song YF; Tang YL; Chen Y
    Med Oncol; 2013; 30(2):571. PubMed ID: 23649549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of CK19 and VEGF gene expression, ki67 antigen, p53 protein, C-erb-B2, and their relationship in oral squamous cell carcinoma.
    Shen Y; Xu Z; Liu M; Piao S; Li J
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):233-239. PubMed ID: 35818248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Correlation Between CD44 and Angiogenesis in Oral Squamous Cell Carcinoma Induced in Buccal Pouch in Syrian Hamster that Underwent Radiotherapy.
    Alsafadi R; Manadili A
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3571-3576. PubMed ID: 36308384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma.
    Shang ZJ; Li JR; Li ZB
    J Oral Maxillofac Surg; 2007 Jan; 65(1):17-21. PubMed ID: 17174758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma.
    Shintani S; Li C; Ishikawa T; Mihara M; Nakashiro K; Hamakawa H
    Oral Oncol; 2004 Jan; 40(1):13-20. PubMed ID: 14662410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression.
    Chuang JY; Chen PC; Tsao CW; Chang AC; Lein MY; Lin CC; Wang SW; Lin CW; Tang CH
    Oncotarget; 2015 Feb; 6(6):4239-52. PubMed ID: 25738362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.